Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Krause, Nicole ORCID: 0000-0001-6681-7054, Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Rahn, Anne Christin ORCID: 0000-0002-9051-3621, Pöttgen, Jana ORCID: 0000-0002-6665-2154, Köpke, Sascha ORCID: 0000-0003-4106-4919, Meyer, Björn, Thale, Frithjof ORCID: 0000-0002-2721-1620, Temmes, Herbert, van de Loo, Markus, Gold, Stefan M. ORCID: 0000-0001-5188-4799 and Heesen, Christoph ORCID: 0000-0001-8131-9467 (2022). ‘That would have been the perfect thing after diagnosis’: development of a digital lifestyle management application in multiple sclerosis. Therapeutic Advances in Neurological Disorders, 15. p. 175628642211187. SAGE. ISSN 1756-2864

Rahn, Anne C., Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Alegiani, Anna, Pust, Gesa E. A., van de Roemer, Adrianus, Schmitz, Leonie, Vettorazzi, Eik ORCID: 0000-0002-3737-6402, Kopke, Sascha and Heesen, Christoph (2021). Comprehension of confidence intervals in audio-visual patient information materials for people with multiple sclerosis (COCO-MS): A web-based randomised controlled, parallel group trial. Patient Educ. Couns., 104 (5). S. 1132 - 1140. CLARE: ELSEVIER IRELAND LTD. ISSN 1873-5134

Rahn, Anne C. ORCID: 0000-0002-9051-3621, Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Alegiani, Anna Christina ORCID: 0000-0001-8216-6220, Pust, Gesa E. A., van de Roemer, Adrianus, Schmitz, Leonie, Vettorazzi, Eik ORCID: 0000-0002-3737-6402, Köpke, Sascha ORCID: 0000-0003-4106-4919 and Heesen, Christoph ORCID: 0000-0001-8131-9467 (2021). Comprehension of confidence intervals in audio-visual patient information materials for people with multiple sclerosis (COCO-MS): A web-based randomised controlled, parallel group trial. Patient Education and Counseling, 104 (5). pp. 1132-1139. Elsevier. ISSN 0738-3991

Barabasch, Anna ORCID: 0000-0001-5301-5714, Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Kofahl, Christopher ORCID: 0000-0002-0503-3077, Scheiderbauer, Jutta, Eklund, Desiree, Kleiter, Ingo ORCID: 0000-0002-8249-4408, Kasper, Jürgen, Köpke, Sascha ORCID: 0000-0003-4106-4919, Lezius, Susanne ORCID: 0000-0002-4832-4333, Zapf, Antonia ORCID: 0000-0002-8467-0508, Rahn, Anne Christin ORCID: 0000-0002-9051-3621 and Heesen, Christoph ORCID: 0000-0001-8131-9467 (2021). Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design. Pilot and Feasibility Studies, 7 (1). BMC. ISSN 2055-5784

Krause, Nicole ORCID: 0000-0001-6681-7054, Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Steffen, Tanja, Rahn, Anne Christin, Pottgen, Jana, Stellmann, Jan-Patrick ORCID: 0000-0003-2565-2833, Kopke, Sascha ORCID: 0000-0003-4106-4919, Friede, Tim ORCID: 0000-0001-5347-7441, Icks, Andrea, Vomhof, Markus ORCID: 0000-0002-2714-6371, Temmes, Herbert, van de Loo, Markus, Gold, Stefan M. and Heesen, Christoph (2021). Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1). BMJ Open, 11 (2). LONDON: BMJ PUBLISHING GROUP. ISSN 2044-6055

Krause, Nicole ORCID: 0000-0001-6681-7054, Riemann-Lorenz, Karin ORCID: 0000-0002-0779-2640, Steffen, Tanja, Rahn, Anne Christin ORCID: 0000-0002-9051-3621, Pöttgen, Jana ORCID: 0000-0002-6665-2154, Stellmann, Jan-Patrick ORCID: 0000-0003-2565-2833, Köpke, Sascha ORCID: 0000-0003-4106-4919, Friede, Tim ORCID: 0000-0001-5347-7441, Icks, Andrea ORCID: 0000-0002-4882-969X, Vomhof, Markus ORCID: 0000-0002-2714-6371, Temmes, Herbert, van de Loo, Markus, Gold, Stefan M ORCID: 0000-0001-5188-4799 and Heesen, Christoph ORCID: 0000-0001-8131-9467 (2021). Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1). BMJ Open, 11 (2). e041720. BMJ PUBLISHING GROUP. ISSN 2044-6055

This list was generated on Sat Oct 5 16:35:23 2024 CEST.